You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Camber Capital Management | 0 | 1,700,000 | 0 | 1,700,000 | Camber% | |
| Stephen DuBois Not applicable | 0 | 1,700,000 | 0 | 1,700,000 | Stephen% |
Follow Stephen Dubois's Camber Capital Management
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 1 of 6 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. 1)
Under the Securities Exchange Act of
1934
1934
AMAG Pharmaceuticals,
Inc.
Inc.
(Name of
Issuer)
Issuer)
Common Stock, par value $0.01 per
share
share
(Title of Class of
Securities)
Securities)
00163U106
(CUSIP
Number)
Number)
May 23, 2017
(Date of Event
Which Requires Filing of this Statement)
Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this
Schedule is filed:
appropriate box to designate the rule pursuant to which this
Schedule is filed:
☐ Rule
13d-1(b)
13d-1(b)
☒
Rule
13d-1(c)
Rule
13d-1(c)
☐ Rule
13d-1(d)
13d-1(d)
*The remainder of
this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover
page.
this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover
page.
The information
required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise
subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the
Notes).
required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise
subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the
Notes).
Persons who respond to the collection of
information contained in this form are not
required to respond unless the form displays a currently valid OMB
control number.
information contained in this form are not
required to respond unless the form displays a currently valid OMB
control number.
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 1 of 6
